<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02848</article-id><article-id pub-id-type="doi">10.7554/eLife.02848</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Allosteric inhibition of a stem cell RNA-binding protein by an intermediary metabolite</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-12484"><name><surname>Clingman</surname><given-names>Carina C</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry and Molecular Pharmacology</named-content></addr-line>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12485"><name><surname>Deveau</surname><given-names>Laura M</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry and Molecular Pharmacology</named-content></addr-line>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12486"><name><surname>Hay</surname><given-names>Samantha A</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry and Molecular Pharmacology</named-content></addr-line>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12487"><name><surname>Genga</surname><given-names>Ryan M</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry and Molecular Pharmacology</named-content></addr-line>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12488"><name><surname>Shandilya</surname><given-names>Shivender MD</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry and Molecular Pharmacology</named-content></addr-line>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12489"><name><surname>Massi</surname><given-names>Francesca</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry and Molecular Pharmacology</named-content></addr-line>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-12304"><name><surname>Ryder</surname><given-names>Sean P</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry and Molecular Pharmacology</named-content></addr-line>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country><email>sean.ryder@umassmed.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-2085"><name><surname>Black</surname><given-names>Douglas L</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>06</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02848</elocation-id><supplementary-material><ext-link xlink:href="elife-02848-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>19</day><month>03</month><year>2014</year></date><date date-type="accepted"><day>15</day><month>06</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Clingman et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Clingman et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Gene expression and metabolism are coupled at numerous levels. Cells must sense and respond to nutrients in their environment, and specialized cells must synthesize metabolic products required for their function. Pluripotent stem cells have the ability to differentiate into a wide variety of specialized cells. How metabolic state contributes to stem cell differentiation is not understood. Here, we show that RNA-binding by the stem cell translation regulator Musashi-1 (MSI1) is allosterically inhibited by 18-22 carbon ω-9 monounsaturated fatty acids. The fatty acid binds to the N-terminal RNA Recognition Motif (RRM) and induces a conformational change that prevents RNA association. Musashi proteins are critical for development of the brain, blood, and epithelium. We identify stearoyl-CoA desaturase-1 as a MSI1 target, revealing a feedback loop between ω-9 fatty acid biosynthesis and MSI1 activity. We propose that other RRM proteins could act as metabolite sensors to couple gene expression changes to physiological state.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd><kwd>Other</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>